e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Unravelling molecular mysteries of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD
M. Sanzharovskaya, G. Chernogoryuk, N. Varvyanskaya, N. Jamkina, A. Smotrova (Tomsk, Russian Federation)
Source:
Annual Congress 2007 - Unravelling molecular mysteries of COPD
Session:
Unravelling molecular mysteries of COPD
Session type:
Thematic Poster Session
Number:
933
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sanzharovskaya, G. Chernogoryuk, N. Varvyanskaya, N. Jamkina, A. Smotrova (Tomsk, Russian Federation). Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 933
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Associations between BODE index and systemic inflammatory biomarkers in COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Tussive mediators in induced sputum in patients with chronic cough: Relationship with clinical measures
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Relationship between peroxidation and antioxidant status in induced sputum and BODE-index in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 634s
Year: 2006
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept